HOME >> MEDICINE >> NEWS
GlaxoSmithKline Drug Discovery and Development Award 2002

Six HIV and AIDS researchers will split $500,000 as this year's recipients of the GlaxoSmithKline (GSK) Drug Discovery and Development Award. The unrestricted research award program is funded by GSK to support independent, innovative and novel research in the development of HIV/AIDS therapeutics.

An Expert Review Board, composed of researchers who are leaders in the field of HIV/AIDS, independently judged and selected the award recipients. John A. Bartlett, M.D., professor of medicine at Duke University Medical Center; David D. Ho, M.D., professor at Rockefeller University and scientific director at Aaron Diamond AIDS Research Center; and Michael Saag, M.D., associate professor of medicine and director of the AIDS Outpatient Clinic at the University of Alabama at Birmingham, served on the board this year.

Recipients of the awards are Irwin Chaiken, Ph.D., University of Pennsylvania, Philadelphia, for his work studying the interactions between proteins that allow HIV to recognize and enter a host cell, research that potentially will lead to drugs that prevent the virus-cell fusion process; Nouri Neamati, Ph.D., University of Southern California School of Pharmacy, Los Angeles, for work in identifying the drug-binding site on HIV integrase, which should lead to development of second- and third-generation drugs that inhibit that enzyme; Alan C. Sartorelli, Ph.D., Yale University School of Medicine, New Haven, Conn., for his research on making certain enzyme inhibitors work more effectively; Nan-Sook Lee, Ph.D., Beckman Institute of the City of Hope, Duarte, Calif., for her research using gene therapy as a potential HIV/AIDS treatment; Elias Lolis, Ph.D., Yale University School of Medicine, for his work in attempting to solve likely side effects of some of the experimental entry inhibitor drugs; and Min Lu, Ph.D., Weill Medical College of Cornell University, New York, N.Y., for his research of a drug developed for herpes that may eventually be used for
'"/>

Contact: Elaine Salewske
esalewske@pcipr.com
312-558-1770
Public Communications Inc.
1-Oct-2002


Page: 1 2 3 4 5

Related medicine news :

1. TB Alliance announces new drug discovery program with GlaxoSmithKline
2. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
3. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
4. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003
6. GlaxoSmithKline Drug Discovery and Development Award 2002
7. Discovery of pathway in learning impairment caused by liver disease may lead to drug treatment
8. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
9. Discovery of the oldest remains of a woman who died in childbirth
10. Discovery sheds light on how cancer cells grow and divide
11. Discovery changes ideas about damage from strokes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... Talented host, actor Rob Lowe, is introducing a segment ... of "Success Files," which is an award-winning educational program broadcasted on PBS Member ... with passion and integrity. , Sciatica occurs when the sciatic nerve in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology:
Cached News: